Literature DB >> 23090716

Paclitaxel increases high voltage-dependent calcium channel current in dorsal root ganglion neurons of the rat.

Kazuyoshi Kawakami1, Terumasa Chiba, Nobuyuki Katagiri, Maya Saduka, Kenji Abe, Iku Utsunomiya, Toshihiro Hama, Kyoji Taguchi.   

Abstract

Peripheral neuropathic pain is a serious side effect of paclitaxel treatment. However, the mechanism of this paclitaxel-induced neuropathic pain is unknown. In this study, we investigated the effects of paclitaxel on the voltage-dependent calcium channel (VDCC) current in rat dorsal root ganglion (DRG) neurons using the whole-cell patch clamp technique. Behavioral assessment using von Frey filament stimuli showed that 2 and 4 mg/kg paclitaxel treatment induced mechanical allodynia/hyperalgesia. Paclitaxel-induced mechanical hyperalgesia was significantly inhibited by gabapentin (100 mg/kg). Using the patch clamp method, we observed that paclitaxel (4 mg/kg) treatment significantly increased the VDCC current in small- and medium-diameter DRG neurons. Moreover, paclitaxel-induced increase in the VDCC current in medium-diameter DRG neurons was completely inhibited by 10 and 100 μM gabapentin. Similar effects in small-diameter DRG neurons were only seen with 100 μM gabapentin. Western blotting revealed that paclitaxel increased protein levels of the VDCC subunit α₂δ-1 (Ca(v)α₂δ-1) in DRG neurons. Immunohistochemistry showed that paclitaxel treatment increased Ca(v)α₂δ-1 protein expression in DRG neurons. Thus, paclitaxel treatment increases the VDCC current in small- and medium-diameter DRG neurons and upregulates Ca(v)α₂δ-1. The antihyperalgesic action of gabapentin may be due to inhibition of paclitaxel-induced increases in the VDCC current in DRG neurons.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23090716     DOI: 10.1254/jphs.12123fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  10 in total

1.  Nerve growth factor alters microtubule targeting agent-induced neurotransmitter release but not MTA-induced neurite retraction in sensory neurons.

Authors:  Sherry K Pittman; Neilia G Gracias; Jill C Fehrenbacher
Journal:  Exp Neurol       Date:  2016-02-13       Impact factor: 5.330

2.  Paclitaxel alters the evoked release of calcitonin gene-related peptide from rat sensory neurons in culture.

Authors:  Sherry K Pittman; Neilia G Gracias; Michael R Vasko; Jill C Fehrenbacher
Journal:  Exp Neurol       Date:  2013-12-26       Impact factor: 5.330

3.  Targeting the CaVα-CaVβ interaction yields an antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy.

Authors:  Rajesh Khanna; Jie Yu; Xiaofang Yang; Aubin Moutal; Aude Chefdeville; Vijay Gokhale; Zunaira Shuja; Lindsey A Chew; Shreya S Bellampalli; Shizhen Luo; Liberty François-Moutal; Maria J Serafini; Taehwan Ha; Samantha Perez-Miller; Ki Duk Park; Amol M Patwardhan; John M Streicher; Henry M Colecraft; May Khanna
Journal:  Pain       Date:  2019-07       Impact factor: 7.926

4.  Sexual dimorphism in the contribution of neuroendocrine stress axes to oxaliplatin-induced painful peripheral neuropathy.

Authors:  Larissa Staurengo-Ferrari; Paul G Green; Dionéia Araldi; Luiz F Ferrari; Christine Miaskowski; Jon D Levine
Journal:  Pain       Date:  2021-03-01       Impact factor: 7.926

5.  Sodium channel Nav1.7 expression is upregulated in the dorsal root ganglia in a rat model of paclitaxel-induced peripheral neuropathy.

Authors:  Zhongyuan Xia; Yun Xiao; Yang Wu; Bo Zhao
Journal:  Springerplus       Date:  2016-10-06

6.  Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; cause and effect?

Authors:  Kelly Ann Aromolaran; Peter A Goldstein
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

7.  Paclitaxel Induces Upregulation of Transient Receptor Potential Vanilloid 1 Expression in the Rat Spinal Cord.

Authors:  Yukako Kamata; Toshie Kambe; Terumasa Chiba; Ken Yamamoto; Kazuyoshi Kawakami; Kenji Abe; Kyoji Taguchi
Journal:  Int J Mol Sci       Date:  2020-06-18       Impact factor: 5.923

8.  Prokineticin Receptor Inhibition With PC1 Protects Mouse Primary Sensory Neurons From Neurotoxic Effects of Chemotherapeutic Drugs in vitro.

Authors:  Giorgia Moschetti; Theodora Kalpachidou; Giada Amodeo; Roberta Lattanzi; Paola Sacerdote; Michaela Kress; Silvia Franchi
Journal:  Front Immunol       Date:  2020-09-24       Impact factor: 7.561

Review 9.  Emerging Approaches for the Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Therapeutic Potential of the C5a/C5aR Axis.

Authors:  Maria C Spera; Maria C Cesta; Mara Zippoli; Giustino Varrassi; Marcello Allegretti
Journal:  Pain Ther       Date:  2022-09-13

10.  Functional Interaction between Transient Receptor Potential V4 Channel and Neuronal Calcium Sensor 1 and the Effects of Paclitaxel.

Authors:  Julio C Sánchez; Barbara E Ehrlich
Journal:  Mol Pharmacol       Date:  2021-07-28       Impact factor: 4.054

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.